Here are five points:
1. Zacks currently has a $38 price target on the stock.
2. Smith & Nephew has a consensus rating of “hold” and a consensus target price of $39.25 from all the brokerages covering the firm.
3. The company’s stock has a 50-day moving average of $32.91 and a 200-day moving average of $33.54.
4. Smith & Nephew has a one-year low of $30.23 and a one-year high of $37.84.
5. The stock has a market cap of $15.2 billion.
More articles on devices:
Rush Health partners with United Airlines to provide orthopedic, spine procedures: 4 observations
Expanding Orthopedics appoints Dale Binke as VP: 3 things to know
EOS imaging’s spineEOS receives FDA approval: 4 key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
